ÂÜÀòÂÒÂ×

Nadine Sprangers has extensive experience in the pharmaceutical industry, with a focus on pricing, market access, and regulatory affairs. Nadine is currently the Vice President and Head of Global Oncology Value, Access & Pricing at Daiichi Sankyo, Inc. Prior to this, they held various leadership roles at Daiichi Sankyo Europe GmbH, including Vice President of EU Head of Pricing, Market Access, HEOR & RWD, Executive Director of Pricing, Economics and Market Access Strategy, Executive Director of Pricing Reimbursement and Access, and Senior Director of Pricing Reimbursement Access, Europe. Before joining Daiichi Sankyo, Nadine worked as a Senior Manager of Global Strategic Pricing at GlaxoSmithKline Biologicals and as a Manager of Market Access at Bristol Myers Squibb. Nadine started their career at Altana Pharma as a Manager of Regulatory Affairs.

Nadine Sprangers holds a Master's degree in Health Economics from VLEKHO Business School Brussel, which they obtained from 2004 to 2005. Nadine also has a Master's degree in Industrial Pharmacy from an Interuniversity program (Antwerp, Leuven, Brussels, Ghent) between 1996 and 1998. Additionally, they have a Master's degree in Pharmaceutical Sciences from the University of Antwerp, completed from 1991 to 1996. Their secondary education was completed at Sint-Jozef college Turnhout from 1985 to 1991, with a focus on Latin-Sciences.